Aggregates Associated with Instability of Antibodies during Aerosolization Induce Adverse Immunological Effects - Archive ouverte HAL Access content directly
Journal Articles Pharmaceutics Year : 2022

Aggregates Associated with Instability of Antibodies during Aerosolization Induce Adverse Immunological Effects

(1) , (1, 2) , (1) , (1, 2) , (1) , (1, 2) , (3, 4, 5) , (1) , (6) , (1, 2) , (1)
1
2
3
4
5
6

Abstract

Background: Immunogenicity refers to the inherent ability of a molecule to stimulate an immune response. Aggregates are one of the major risk factors for the undesired immunogenicity of therapeutic antibodies (Ab) and may ultimately result in immune-mediated adverse effects. For Ab delivered by inhalation, it is necessary to consider the interaction between aggregates resulting from the instability of the Ab during aerosolization and the lung mucosa. The aim of this study was to determine the impact of aggregates produced during aerosolization of therapeutic Ab on the immune system. Methods: Human and murine immunoglobulin G (IgG) were aerosolized using a clinically-relevant nebulizer and their immunogenic potency was assessed, both in vitro using a standard human monocyte-derived dendritic cell (MoDC) reporter assay and in vivo in immune cells in the airway compartment, lung parenchyma and spleen of healthy C57BL/6 mice after pulmonary administration. Results: IgG aggregates, produced during nebulization, induced a dose-dependent activation of MoDC characterized by the enhanced production of cytokines and expression of co-stimulatory markers. Interestingly, in vivo administration of high amounts of nebulization-mediated IgG aggregates resulted in a profound and sustained local and systemic depletion of immune cells, which was attributable to cell death. This cytotoxic effect was observed when nebulized IgG was administered locally in the airways as compared to a systemic administration but was mitigated by improving IgG stability during nebulization, through the addition of polysorbates to the formulation. Conclusion: Although inhalation delivery represents an attractive alternative route for delivering Ab to treat respiratory infections, our findings indicate that it is critical to prevent IgG aggregation during the nebulization process to avoid pro-inflammatory and cytotoxic effects. The optimization of Ab formulation can mitigate adverse effects induced by nebulization.
Fichier principal
Vignette du fichier
10.3390-pharmaceutics14030671_Secher_et_al_2022.pdf (1.23 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03687448 , version 1 (03-06-2022)

Identifiers

Cite

Thomas Sécher, Elsa Bodier-Montagutelli, Christelle Parent, Laura Bouvart, Mélanie Cortes, et al.. Aggregates Associated with Instability of Antibodies during Aerosolization Induce Adverse Immunological Effects. Pharmaceutics, 2022, 14 (3), pp.671. ⟨10.3390/pharmaceutics14030671⟩. ⟨hal-03687448⟩
20 View
16 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More